TheChek News Flow

PRN 10/09 10:30 Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
BN 10/09 10:33 *ENDO DEAL VALUED AT $2.6B, INCL REPAYMENT, ASSUMPTION OF DEBT
BFW 10/09 10:33 *AUXILIUM TERMINATED PROPOSED MERGER PACT WITH QLT
BN 10/09 10:32 *ENDO TO FINANCE DEAL W/CASH ON HAND, COMMITMENT FROM CITI
BN 10/09 10:31 *AUXILIUM TERMINATED PROPOSED MERGER PACT WITH QLT
BN 10/09 10:31 *ENDO: PRICE REPRESENTS PREMIUM OF 55% TO AUXL'S CLOSE SEPT 16
BN 10/09 10:30 *ENDO SEES PURCHASE ADDING TO EARNINGS IMMEDIATELY
BFW 10/09 10:30 *ENDO TO BUY AUXILIUM PHARMACEUTICALS FOR $33.25/SHR
BN 10/09 10:30 *ENDO SEES DEAL ADDING TO EARNINGS
BN 10/09 10:30 *ENDO TO BUY AUXILIUM PHARMACEUTICALS FOR $33.25/SHR
BN 10/09 10:30 *ENDO TO BUY AUXILIUM PHARMACEUTICALS IN A CASH & STOCK

Endo to Buy Auxilium Pharmaceuticals for $33.25/Shr
2014-10-09 10:32:15.960 GMT


By Andrew Cinko
Oct. 9 (Bloomberg) -- Endo offering three cash and stock
options: 100% equity which equates to 0.488 Endo shares per
Auxilium share, 100% cash which equates to $33.25 per Auxilium
share or equal mix of $16.625 in cash, 0.244 Endo shares
per Auxilium share.
* Sees deal adding to earnings
* Sees closing in 1H 2015
Link to Statement:{NSN ND6AI33MSFLS <GO>}
Link to Company News:{AUXL US <Equity> CN <GO>}
Link to Company News:{ENDP US <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story:
Andrew Cinko at +1-609-279-4533 or
cinko@bloomberg.net